Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06181214 · ClinicalTrials.gov registry record · NA
The Effects of a Novel Nutritional Product on Nutrient Status and Digestive Health
A NA study, sponsored by Athletic Greens International.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06181214: Completed NA study, sponsored by Athletic Greens International.
NCT06181214 is a NA study that has completed, run by Athletic Greens International. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06181214, a NA study, has completed, sponsored by Athletic Greens International.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is a randomized, double-blind, placebo-controlled study of N=30 apparently healthy men and women. This is an exploratory study to assess the effect of a novel dietary supplement on blood markers of nutrient status and the gut microbiome.
Primary Outcome
Examine changes in the gut microbiome structure and function measured by shallow shotgun metagenomics. Examine enrichment of taxa and metabolic pathways in the gut microbiome as a result of dietary supplementation.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT AG1 - Nutritional Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-08-14 |
| Est. Completion | 2023-10-04 |
| Phase | NA |
What the finished NCT06181214 record still lists
NCT06181214 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06181214 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06181214 about?
NCT06181214 is a clinical study titled "The Effects of a Novel Nutritional Product on Nutrient Status and Digestive Health". This study is a randomized, double-blind, placebo-controlled study of N=30 apparently healthy men and women. This is an exploratory study to assess the effect of a novel dietary supplement on blood markers of nutrient status and the gut microbiome.
What is the current status of trial NCT06181214?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-08-14. Estimated completion is 2023-10-04.
What interventions are being tested in trial NCT06181214?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), AG1 - Nutritional Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06181214?
This trial is sponsored by Athletic Greens International, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06181214's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI